Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

A Systematic Review of Platelet-Rich Plasma Versus Platelet-Rich Fibrin for Periorbital Rejuvenation

Sollitto CF., Narduzzi M., Wolinsky C.

Systematic Review on Skin Aging, Facial Rejuvenation, published in J Cosmet Dermatol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
J Cosmet Dermatol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41190633
PMCID
PMC12587466
DOI
10.1111/jocd.70524
Citations
2

Abstract (original English)

Background Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) have become popular autologous options for facial rejuvenation due to their regenerative potential and favorable safety profiles. The periorbital region remains one of the most challenging treatment sites, as conventional approaches such as hyaluronic acid fillers carry a risk of complications and may not provide natural, sustained results. Aim This systematic review aims to compare injectable PRP and PRF in periorbital rejuvenation, with emphasis on treatment protocols, efficacy, adverse effects, and patient-reported outcomes. Methods A PRISMA-guided search was conducted using PubMed, Embase, and Wiley Library. Included studies were evaluated for differences in preparation, injection techniques, frequency of treatment, clinical outcomes, adverse events, and satisfaction. Results A total of 14 studies met inclusion criteria. Across studies, PRF was associated with improvements in skin texture, wrinkles, and crepiness, while PRP showed stronger evidence for treating hyperpigmentation. Both modalities demonstrated favorable safety profiles and high patient satisfaction, with only mild, transient adverse effects reported. Longevity of results remains unclear: PRF improvements often diminished by 6 months, whereas PRP outcomes for pigmentation were sustained at similar intervals. Conclusion PRF shows promise in im

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
FaceHumansTreatment OutcomeRejuvenationCosmetic TechniquesSkin AgingPatient SatisfactionPlatelet-Rich PlasmaPatient Reported Outcome MeasuresPlatelet-Rich Fibrin

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research